metricas
covid
Buscar en
Revista Argentina de Microbiología
Toda la web
Inicio Revista Argentina de Microbiología Diversity of hypervirulent Klebsiella pneumoniae clones causing cryptogenic live...
Información de la revista
Visitas
187
Original article
Acceso a texto completo
Disponible online el 10 de febrero de 2025
Diversity of hypervirulent Klebsiella pneumoniae clones causing cryptogenic liver abscesses and metastatic complications in Argentina
Diversidad de clones hipervirulentos de Klebsiella pneumoniae causantes de abscesos hepáticos criptogénicos y complicaciones metastásicas en Argentina
Visitas
187
Esteban C. Nanninia,b, Matías Lahitteb, Pablo Scapellatoc, Corina Nemirosvkyd, Marcelo Zylbermane, Andrea Vilaf, Viviana Rodríguezg, Roman Zucchih, Analia Mykietiuki, Valeria Davidj, Adriana Limanskyj, Patricia Marchiaroj, Mariángel Rinaudob,j,
Autor para correspondencia
mariangelrinaudo@gmail.com

Corresponding author.
a Instituto IDICER (CONICET) Rosario – Facultad Ciencias Médicas – Universidad Nacional de Rosario, Suipacha 590, Rosario, Santa Fe, Argentina
b Sanatorio Británico, Paraguay 40, Rosario, Santa Fe, Argentina
c Hospital Santojanni, Pilar 950, Buenos Aires, Argentina
d Hospital Italiano, Juan Domingo Perón 4190, Ciudad Autónoma Buenos Aires, Buenos Aires, Argentina
e Hospital Argerich, Pi y Margall 750, Ciudad Autónoma Buenos Aires, Buenos Aires, Argentina
f Hospital Italiano de Mendoza, Av. De Acceso Este 1070, M5519 San José, Mendoza, Argentina
g Hospital Tornú, Av. Combatientes de Malvinas 3002, Ciudad Autónoma Buenos Aires, Buenos Aires, Argentina
h Clínica Sagrado Corazón, Bartolomé Mitre 1955, Ciudad Autónoma Buenos Aires, Buenos Aires, Argentina
i Instituto Médico Platense, Av. 51 315, La Plata, Buenos Aires, Argentina
j Facultad de Ciencias Bioquímicas y Farmacéuticas – Universidad Nacional de Rosario, Suipacha 531, Rosario, Santa Fe, Argentina
Ver más
Highlights

  • Hypervirulent Klebsiella pneumoniae (hvKP) strains are of public health concern.

  • We report patients with hvKP liver abscesses suffering a high rate of complications.

  • Studied hvKP isolates had rpmA and iroB genes, possibly linked to severe illness.

  • K1 serotypes often belonged to ST23 while K2 strains showed significant diversity.

Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Tablas (3)
Table 1. Primers used for amplification of the target genes of K. pneumoniae isolates.
Tablas
Table 2. Clinical and epidemiological characteristics of 15 patients with cryptogenic liver abscessesa
Tablas
Table 3. Characteristics of the 8 hypervirulent K. pneumoniae clinical strains studieda
Tablas
Mostrar másMostrar menos
Abstract

Cryptogenic liver abscesses (CLA) caused by hypervirulent Klebsiella pneumoniae (hvKP) strains are emerging in Western countries. The aim of the study was to describe the clinical characteristics of patients from Argentina with hvKP-related CLA as well as the molecular analysis of isolated strains. A retrospective chart review of 15 patients hospitalized in 8 hospitals of Argentina between October 2015 and November 2018 was performed. PCR assays for genes associated with capsular and multilocus sequence typing (MLST) determination and virulence factors were conducted in 8 hvKP isolates from these patients. We found that the mean age of patients was 60 years, 73% of them were men and 40% suffered from diabetes. Bacteremia was detected in 60% of them and 73% had ≥1 metastatic foci of infection. There were no in-hospital deaths, but two patients with endophthalmitis required eye enucleation. Of the 8 studied isolates, 4 belonged to K1 and 4 to K2 serotypes, with the rpmA and iroB genes being present in all of them, and isolates 7 and 5 also harboring the iucA and the rmpA2 genes, respectively. MSLT analysis showed that most of the K1 serotypes belonged to ST23 while a diverse MLST pattern was observed among the K2 strains. In addition, the four hvKP strains associated with metastatic complications and belonging to three distinct sequence types, exhibited the rpmA, iroB and iuc virulence genes. We were able to demonstrate important morbidity associated with this syndrome, a significant diversity in the hvKP clones causing CLA in Argentina, and the potential utility of the rpmA and iroB genes as predictors of virulence.

Keywords:
Klebsiella pneumoniae
Cryptogenic liver abscess
Hypermucoviscous
Hypervirulence
Resumen

Los abscesos hepáticos criptogénicos causados por cepas de Klebsiella pneumoniae hipervirulentas (KPhv) están emergiendo en países occidentales. Los objetivos de este trabajo fueron describir las características clínicas de pacientes con abscesos hepáticos criptogénicos asociados a KPhv en Argentina y efectuar el análisis molecular de dichas cepas. Se realizó una revisión retrospectiva de las historias clínicas de 15 pacientes hospitalizados en 8 hospitales entre octubre de 2015 y noviembre de 2018. La metodología incluyó PCR para detectar genes asociados a la cápsula bacteriana y otros factores de virulencia, así como el análisis clonal mediante multilocus sequence typing de 8 aislamientos de KPhv. La edad promedio de los pacientes fue 60 años, el 73% fueron varones y el 40% tenía diabetes. El 60% presentó bacteriemia y el 73% al menos un foco metastásico. No se registraron muertes y 2 pacientes con endoftalmitis requirieron enucleación ocular. De los 8 aislamientos estudiados, 4 presentaron serotipo capsular K1 y los 4 restantes, serotipo capsular K2. Todos los aislamientos portaban los genes rpmA e iroB, mientras que 7 y 5 aislamientos también portaban los genes iucA y rmpA2, respectivamente. El análisis por multilocus sequence typing mostró que la mayoría de las cepas K1 correspondían al secuenciotipo 23, mientras que hubo diversidad entre las cepas K2. Asimismo, las 4 cepas de KPhv asociadas a complicaciones metastásicas, pertenecientes a 3 secuenciotipos distintos, presentaron los genes de virulencia rpmA, iroB e iucA. En suma, pudimos evidenciar una importante morbilidad asociada a este síndrome, una diversidad en los clones de KPhv causantes de abscesos hepáticos criptogénicos en Argentina y la potencial utilidad de los genes rpmA e iroB como predictores de virulencia.

Palabras clave:
Klebsiella pneumoniae
Absceso hepático criptogénico
Hipermucoviscosidad
Hipervirulencia
Texto completo
Introduction

Pyogenic liver abscesses (PLAs) are serious life-threatening infections with an incidence of 1.1 to 17.6 per 100000 persons throughout the world, with a mortality rate of 6–19%, even in treated patients19. PLAs are usually related to biliary obstruction, intra-abdominal infections (i, suppurative pylephlebitis, appendicitis, diverticulitis or peritonitis), and colonic diseases such as inflammatory bowel disease, diverticulitis, colon cancer and polyps. Less frequently, liver abscesses arise from a systemic infection through hematological seeding28. Cryptogenic liver abscesses (CLAs) are designated when no obvious extrahepatic source of infection is identified and they account for about 20% of the PLAs in industrialized countries28.

Since the mid-1980s, reports of CLAs caused by mucoid strains of Klebsiella pneumoniae have been described in countries from the Asian Pacific Rim17. In the following years, an increasing number of cases were reported worldwide22,27 representing a serious emerging infectious disease. These K. pneumoniae strains have been initially termed “hypermucoviscous” due the formation of viscous strings of >5mm in length when a loop is used to stretch the colony (positive “string test”). However, due to their invasiveness, genotypic features, and associated clinical presentation, they were later renamed as hypervirulent K. pneumoniae (hvKP)24,29. Even though the outcome of patients with CLA is more favorable than that of those suffering from non-cryptogenic pyogenic liver abscesses, the typical spread of the infection to other organs has been associated with significant morbidity7,27. Moreover, cases of CLAs caused by multidrug resistant hvKP, including carbapenem-resistant hvKP3, have raised remarkable concerns.

A number of accessory virulence genes have been linked to hvKP strains such as iucA (aerobactin siderophore biosynthesis) and iroB (salmochelin siderophore biosynthesis), as well as rmpA and rmpA2, both of which are involved in increased capsule expression and hypermucoviscosity25,33. Several capsule serotypes were described among hvKP strains, but K1 and K2 account for approximately 70% of them21,24. Furthermore, certain clones appear to predominate within each capsular serotypes; for instance, ST23 is the most frequent sequence type (ST) among K1 strains while ST65/ST375, ST374, ST66, and ST86 among K2 ones15,21,32. Since the documented spread of these hvKP strains represent a serious public health threat, it is critical to have a better understanding of the epidemiological behavior of these strains. As cases of CLAs caused by hvKP have been sporadically reported from Latin America4,31, we aimed to describe the clinical characteristics of 15 hospitalized patients with CLAs from different cities of Argentina and the molecular analysis of 8 hvKP strains isolated from these patients.

Material and methods

Patients with cryptogenic liver abscesses. A retrospective study was conducted obtaining clinical information through the chart reviews from 15 hospitalized patients diagnosed with CLAs in 8 hospitals from 4 different cities in Argentina (Buenos Aires, Rosario, Mendoza, and La Plata) between October 2015 and November 2018. Cases were identified by a surveillance evaluation implemented within a working group in the Argentinian Society of Infectious Diseases (SADI). Clinical data from patients with confirmed CLA caused by hvKP were collected in a preformed spreadsheet. Each case required the presence of the liver abscess and the isolation of this pathogen from samples obtained from blood or liver abscess fluid. The study was approved by a local ethics committee and due to the retrospective nature of the study, the need for a signed informed consent was waived.

Bacterial isolates

From this series of patients, 8 K. pneumoniae isolates recovered from liver abscesses and/or blood cultures exhibiting the hypermucoviscosity phenotype by a positive string test27 were available for further molecular analysis. The string test was considered positive when a viscous string of more than 5mm in length was obtained by stretching the bacterial colonies grown overnight on a blood agar plate with a bacteriological loop. Identification and antimicrobial susceptibility assays were performed using the BD Phoenix™ System (Becton Dickinson).

Identification of virulence-associated genes

Four genes for virulence including iucA, iroB, plasmid-borne rmpA and an isoform rmpA2 were identified by PCR with the specific primers previously reported25,30,36 (Table 1).

Table 1.

Primers used for amplification of the target genes of K. pneumoniae isolates.

Target gene  Primer sequence (5&#¿;3&#¿;)  Size of PCR product (bp)  Reference 
rmpA  F: ACTGGGCTACCTCTGCTTCAR: CTTGCATGAGCCATCTTTCA  535  36 
rmpA2  F: ACGTATGAAGGCTCGATGGATAR: CCTCCTGGAGAGTAAGCATTGT  354  30 
iucA  F2: GCTTATTTCTCCCCAACCCR2: TCAGCCCTTTAGCGACAAG  583  25 
iroB  F1: ATCTCATCATCTACCCTCCGCTCR1: GGTTCGCCGTCGTTTTCAA  235  25 
wzc_K1  F: AGATAGAGGTGTATTGTCGCR: GAGCTCTATATGTTGGATGC  352  6 
orf10_K2  F: TCATACTTGACAGAGGGAGTAGR: ACGATCGTTACAGTGACAAG  321  6 
magA  F: GGTGCTCTTTACATCATTGCR: GCAATGGCCATTTGCGTTAG  1283  36 
Characterization of capsular types

The detection of capsular K1 and K2 serotypes of these hvKP strains was performed by PCR assays previously reported6. The specific primers amplifying the wzc gene were used to identify K1 strains, and those corresponding to the open reading frame (ORF)-10 region from the cps gene cluster to detect K2 ones6. Additionally, a PCR was performed to amplify magA (mucoviscosity-associated gene A), a chromosome gene involved in the biosynthesis of the outer core lipopolysaccharide, encoded on the operon responsible for capsular serotype K1, which has been linked to the K. pneumoniae hypervirulent phenotype36.

Detection of clones employing molecular methods

The clonal relatedness among the hvKP isolates was based on multilocus sequence typing (MLST) performed by amplification and sequencing of the standard seven housekeeping genes of K. pneumoniae according to the Pasteur Institute MLST website (http://bigsdb.pasteur.fr/klebsiella/klebsiella.html).

Results

Fifteen patients diagnosed with CLA caused by hvKP strains were included in the analysis (Table 2). They were non-Asian descent individuals, 11 (73%) of whom were men with a mean age of 60 years (range: 45–77 years). Diabetes was the most frequent comorbidity (n=6; 40%) and in 9 (60%) of the cases the corresponding hvKP strain was isolated from blood cultures. Percutaneous drainage of the liver abscess was performed in most study patients (n=12; 80%), although in two (13%) individuals, an open surgical procedure was required. Eleven patients (73%) had clinical and radiological confirmation of at least one metastatic focus of infection: 4 patients had one, 6 had two, and one had three. The anatomical sites of infection spread outside the liver are listed in Table 2.

Table 2.

Clinical and epidemiological characteristics of 15 patients with cryptogenic liver abscessesa

Case numbera  Hospitalb  Date  Sex  Age (years)  Underlying condition/risk factor  Positive blood cultures  Procedures  Antibiotic treatment  Metastatic foci  Days of iv treatment 
#1  HA_BA  10/2015  77  None  No  None  CRO  Lung/septic arthritis  14 
#2  HA_BA  05/2016  71  None  No  Percut drainage  CAZ  Endophthalmitis  21 
#3  HA_BA  04/2017  48  DBT  No  Percut drainage/surgical  CRO  Empyema  26 
#4  SB_R  06/2016  67  None  No  Percut drainage  SAM  Epidural abscess  28 
#5*  SB_R  08/2017  55  DBT  Yes  Percut drainage  SAM  None  42 
#6*  SB_R  08/2017  59  DBT  No  Percut drainage  CRO  None  30 
#7*  HI_M  04/2017  63  None  Yes  Percut drainage  SAM  None  14 
#8  HI_BA  11/2017  68  Hypertension, obesity  Yes  Percut drainage  CRO  Endophthalmitis/lung  30 
#9  HI_BA  06/2018  68  None  No  Percut drainage  CRO  Endophthalmitis/empyema  28 
#10*  HI_BA  11/2018  74  Hypertension, obesity  Yes  Submand abscess drainage  SAM  Submandibular abscess  10 
#11*  HS_BA  09/2018  48  DBT, alcoholism, stroke  Yes  Percut drainage  SAM  Lung/empyema  42 
#12*  HS_BA  09/2018  55  DBT  Yes  Percut drainage/surgical  CIP  Peritonitis/prostatic abscess/neck SSTI  26 
#13  HT_BA  09/2018  63  DBT, hypertension  Yes  None  SAM  Lung/suprahepatic thrombophlebitis  21 
#14*  IMP_LP  06/2019  47  None  Yes  Percut drainage  CRO  None  64 
#15*  SSC_BA  06/2019  45  None  Yes  Percut drainage/surgical  SAM  Lung  20 

M: male; F: female; DBT: diabetes; IV treatment: intravenous treatment; SSTI: skin soft tissue infections; CRO: ceftriaxone; CAZ: ceftazidime; SAM: ampicillin/sulbactam; CIP: ciprofloxacin; ND: not determined; Percut: percutaneous.

a

The cases are ordered taking into account the chronology as revealed by the first strain found in each hospital (dates in bold for the first one) but grouped together with the subsequent cases for each hospital. The strains recovered from cases #5, #6, #7, #10, #11, #12, #14 and #15, indicated with asterisks (*), are included in this study for molecular characterization (see Table 3).

b

HA_BA: Hospital Argerich, Buenos Aires; SB_R: Sanatorio Británico, Rosario; HI_M: Hospital Italiano, Mendoza; HI_BA: Hospital Italiano, Buenos Aires; HS_CABA: Hospital Santojanni, Buenos Aires; HT_BA: Hospital Tornu, Buenos Aires; IMP_BA: Instituto Médico Platense, La Plata, Provincia de Buenos Aires; SSC_BA: Sanatorio Sagrado Corazón, Buenos Aires.

Reflecting the severity of the CLA, intravenous antibiotic treatment was administered for a mean of 32 days (range: 14–64 days). All the patients were considered cured at the end of hospitalization although two patients with endophthalmitis required eye enucleation. The 15 isolates were reported as susceptible to all the tested antibiotics except ampicillin, to which K. pneumoniae is intrinsically resistant.

The eight available K. pneumoniae isolates for analysis displayed a positive string test and carried the plasmid-mediated rpmA virulence gene (Table 3) compatible with the hypermucoviscous phenotype, also uncovering its association to the K. pneumoniae hypervirulent pathotype14. In addition, other genes associated with hvKP strains, such as the iroB in all the 8 isolates, and the iucA and the rmpA2 in the 7 and 5 isolates, were identified. K1 isolates were positive for the wzc_K1 and the magA gene (renamed as wzy_K1)35 and the ORF-10 region from the cps gene cluster were found in K2 ones (Table 3).

Table 3.

Characteristics of the 8 hypervirulent K. pneumoniae clinical strains studieda

Strain from case #  String test  Virulence genesK1/K2 serotype PCR result  Sequence type (ST) 
    rpmA  rmpA2  iroB  iucA     
#5  −  −  K1  ST571 
#6  K2  ST65 
#7  −  K2  ST375 
#10  K1  ST23 
#11  K2  ST86 
#12  K1  ST23 
#14  K1  ST23 
#15  −  K2  ST3690 
a

+: positive; − negative.

The MLST analysis showed that, among the 4 K1 strains, 3 belonged to ST23 and one to ST571, while the K2 ones were represented by diverse STs, including ST65 and ST375 (from the same clonal complex)37, ST86, and the most recently described ST369021 (Table 3).

Overall, these results revealed that the K1/ST23 strains exhibited all the virulence genes included in this study (Table 3). Interestingly, all the K2 strains characterized here were positive for the rpmA, iroB and iucA genes (Table 3). In turn, the association between the presence of metastatic foci and the involved strains showed that metastatic complications were observed in 4 of the 8 cases characterized in this study. Specifically, the four hvKP strains associated with metastatic complications, belonging to three distinct sequence types including K1/ST23 (#10 and #12), K2/ST86 (#11), and K2/ST3690 (#15) hvKP strains (Table 2), demonstrated clonal diversity.

Discussion

This is the largest series of patients with CLA reported from Latin America, including the molecular analysis of 8 hvKP strains. In agreement with previous studies1,22,29, we found that all the cases were community-acquired infections, men were the predominant sex, diabetes was the most common comorbidity, more than 50% of the patients had positive blood cultures, the isolated K. pneumoniae strains were susceptible to the majority of the antibiotics tested, and a satisfactory outcome was observed in the majority of the patients by the end of their hospital stay. However, we observed that 73% of the patients developed at least one focus of metastatic infection spread. This rate is considerably higher than that reported by others, ranging between 3.5% and 20% in one study13 and 10–45% in another18.

The most common diagnoses resulting from the infection spread were lung abscesses, empyema, endophthalmitis, and involvement of various other anatomical sites such as prostatic and epidural abscesses. Almost half of the patients from our cohort suffered from more than one infected site outside the liver. We cannot find a plausible justification for the observed high rate of metastatic complications. An unmeasured delay in hospitalization and/or in the drainage of liver abscesses could be a hypothesis, particularly in the 60% of the patients who had bacteremia. It should be noted that three patients (20%) developed endogenous endophthalmitis, the most threatened complication of this syndrome, a considerably higher incidence than the 4.5% reported in a systematic review11 of 11889 patients. These two patients underwent eye enucleation, highlighting the importance of the ophthalmologic screening in patients with CLA for an early diagnosis, treatment, and visual preservation26.

The pheno-genotypic characterization of the 8 hvKP strains analyzed from this cohort of patients showed equal distribution of K1 and K2 serotypes. Most of the K1 strains belonged to the ST23 clone, which is considered the archetypal clone among K1 hvKP strains34. Additionally, the finding of this clone in patients from different hospitals (Table 3) highlights their widespread distribution in the community. This type of clonality pattern among K1/K2 capsular serotypes has already been described22.

Siderophores and mucoid regulators appear to play key roles in conferring the hypervirulent phenotype to these K. pneumoniae strains, and the plasmid-associated genes iuc, iro, and rmpA/rmpA2 have been recognized as important predictors for this phenotypic trait12,33.

In this context, we detected these four virulence genes in five of the eight strains analyzed (three K1/ST23 and two K2 strains (ST65 and ST86) (Table 3). It is worth noting that the four strains recovered from patients with metastatic foci (i.e. ST23, ST86 and ST3690 clones) revealed the four mentioned virulence genes, except for the rmpA2 gene in the last clone. In addition, the two virulence genes positive for the 8 studied strains were rpmA and iroB, thus confirming their capacity as pathogenic markers of hvKP.

With regard to pathogenesis, the exact mechanism by which hvKP strains cause CLA is unclear. It was hypothesized that hvKP strains must first colonize the gastrointestinal tract, then cross the intestinal barrier, to later invade the liver; at this stage, the role of liver Kupffer cells and macrophages appear to be critical in the control of the infection process9. In vitro studies have shown that K1 and K2 capsular serotypes were more resistant than non-K1/K2 ones to phagocytosis and intracellular killing by neutrophils16.

The definition of hvKP has not been clearly outlined and indeed, none of the phenotypic or genotypic tests alone is specific for hypervirulence. However, the presence of hypercapsule, macromolecular exopolysaccharide or excessive siderophores in hvKP and not in classical K. pneumoniae (cKP) strains suggest that these are significant virulence contributors to the observed hypervirulence5. Nonetheless, the role of each virulence factor and the degree of involvement in these strains have been difficult to ascertain. Animal models have confirmed the increased lethality of hvKP strains compared to cKP and partially virulent hvKP strains, although this was observed in some but not all of the mouse models tested23.

Except for intrinsic resistance to ampicillin, hvKP strains are commonly susceptible to a variety of antibiotics; however, the occurrence of liver abscesses caused by hvKP strains carrying multidrug resistant genes have been initially reported with strains carrying extended-spectrum beta-lactamases genes15 in China and in Brazil20. More worrisome, a recent report from Wuhan, China, found that 24 of 45 (53%) clinical hvKP isolates were carbapenemase producers and that 8 of them, although clonally related, were co-producers of NDM-1 and KPC-210. High-risk ST23 hvKp strains producing KPC-2 and dual-carbapenemase-producing KPC-2/VIM-1 were reported in Argentina2 and Chile8, respectively. This occurrence certainly carries potentially serious public health consequences.

The main limitations of this study include the retrospective nature of the reports from each participating hospital, which could have led to a selection bias towards patients with more extensive disease and the limited number of hvKP strains available for molecular analysis.

Conclusions

The CLA syndrome caused by community-acquired strains of hvKP is an emerging worldwide public health concern. We report a series of cases from Argentina highlighting a significant prevalence of metastatic foci of infection. Attending physicians should be aware of this syndrome to provide the appropriate treatment and prevent significant central nervous system or sight-threatening ophthalmologic complications due to hvKP. The hypermucoviscous phenotype of the hvKP strains can be identified using the positive string test and PCR for virulence genes such as rmpA and/or iroB. Epidemiological and molecular studies analyzing the relationship between hvKP cloning spreads and susceptible hosts continue to be crucial, as well as the progressive acquisition of virulence genes among multi-drug resistant clones of K. pneumoniae.

CRediT authorship contribution statement

The authors declare that they have all contributed to the conceptualization and methodology of the study. ECN: original draft writing, data collection, supervision, and revision and editing of the writing. ML, PS, CN, MZ, VR, RZ: data collection; AV and AM: data collection, writing review and editing; AL, PM, MR and VD: laboratory studies, writing revision and editing.

Ethical approval

The study was approved by the Institutional Review Board (IRB) of the Sanatorio Británico, Rosario, Argentina and by each local Ethics Committee.

Consent to participate

Since this was a retrospective study, the bacterial analysis was conducted years after the patients’ episodes of infection, and confidentiality and anonymity were reassured throughout the data collection process. The need for a signed informed consent was waived.

Consent to publish

As there are no individual details, imaging or videos, the consent for publication was waived.

Funding

The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.

Conflict of interest

The authors have no relevant financial or non-financial interests to disclose.

Acknowledgments

We wish to thank the clinical and microbiology staff of each participating hospital.

References
[1]
J. Cardenas-Alvarez, G. Balayla, A. Triana, R. Diaz Lankenau, C. Franco-Paredes, A.F. Henao-Martínez, G. Motoa.
Clinical spectrum and outcomes of cryptogenic Klebsiella pneumoniae liver abscess in the Americas: a scoping review.
[2]
D. Cejas, L. Fernández Canigia, G. Rincón Cruz, A.X. Elena, I. Maldonado, G.O. Gutkind, M.A. Radice.
First isolate of KPC-2-producing Klebsiella pneumoniae sequence type 23 from the Americas.
J Clin Microbiol, 52 (2014), pp. 3483-3485
[3]
H. Chen, L. Fang, W. Chen, Q. Yang, D. Li, D. Hu, J. Zhang.
Pyogenic liver abscess-caused Klebsiella pneumoniae in a tertiary hospital in China in 2017: implication of hypervirulent carbapenem-resistant strains.
BMC Infect Dis, 22 (2022), pp. 685
[4]
R.L. Coutinho, M.F. Visconde, F.J. Descio, A.G. Nicoletti, F.C. Pinto, A.C.R. da Silva, F. Rodrigues-Costa, A.C. Gales, G.H. Furtado.
Community-acquired invasive liver abscess syndrome caused by a K1 serotype Klebsiella pneumoniae isolate in Brazil: a case report of hypervirulent ST23.
Mem Inst Oswaldo Cruz, 109 (2014), pp. 970-971
[5]
P. Dai, D. Hu.
The making of hypervirulent Klebsiella pneumoniae.
J Clin Lab Anal, 36 (2022), pp. e24743
[6]
M.M. Feizabadi, N. Raji, S. Delfani.
Identification of Klebsiella pneumoniae K1 and K2 capsular types by PCR and Quellung test.
Jundishapur J Microbiol, 6 (2013), pp. e7585
[7]
D. Fernández Vecilla, M.J. Unzaga Barañano, C. García de Andoin Sojo, J.L. Díaz de Tuesta del Arco.
Klebsiella pneumoniae hipervirulenta ST23 como causa de neumonía cavitada y sepsis [Cavitary pneumonia and sepsis caused by ST23 hypervirulent Klebsiella pneumoniae].
Enferm Infecc Microbiol Clin (Engl Ed), 41 (2023), pp. 129-131
[8]
M. Gálvez-Silva, P. Arros, C. Berríos-Pastén, A. Villamil, P.I. Rodas, I. Araya, R. Iglesias, P. Araya, J.C. Hormazábal, C. Bohle, Y. Chen, Y.-H. Gan, F.P. Chávez, R. Lagos, A.E. Marcoleta.
Carbapenem-resistant hypervirulent ST23 Klebsiella pneumoniae with a highly transmissible dual-carbapenemase plasmid in Chile.
[9]
C.H. Hoh, Y.H. Tan, Y.-H. Gan.
Protective role of kupffer cells and macrophages in Klebsiella pneumoniae-induced liver abscess disease.
[10]
Y. Huang, J. Li, Q. Wang, K. Tang, X. Cai, C. Li.
Detection of carbapenem-resistant hypervirulent Klebsiella pneumoniae ST11-K64 co-producing NDM-1 and KPC-2 in a tertiary hospital in Wuhan.
J Hosp Infect, 131 (2023), pp. 70-80
[11]
I. Hussain, S. Ishrat, D.C.W. Ho, S.R. Khan, M.A. Veeraraghavan, B.R. Palraj, J.S. Molton, M.B. Abid.
Endogenous endophthalmitis in Klebsiella pneumoniae pyogenic liver abscess: systematic review and meta-analysis.
Int J Infect Dis, 101 (2020), pp. 259-268
[12]
T.J. Kochan, S.H. Nozick, R.L. Medernach, B.H. Cheung, S.W.M. Gatesy, M. Lebrun-Corbin, S.D. Mitra, N. Khalatyan, F. Krapp, C. Qi, E.A. Ozer, A.R. Hauser.
Genomic surveillance for multidrug-resistant or hypervirulent Klebsiella pneumoniae among United States bloodstream isolates.
BMC Infect Dis, 22 (2022), pp. 603
[13]
S.S. Lee, Y. Chen, H. Tsai, S. Wann, H. Lin, C. Huang, Y. Liu.
Predictors of septic metastatic infection and mortality among patients with Klebsiella pneumoniae liver abscess.
Clin Infect Dis, 47 (2008), pp. 642-650
[14]
C.R. Lee, J.H. Lee, K.S. Park, J.H. Jeon, Y.B. Kim, C.J. Cha, B.C. Jeong, S.H. Lee.
Antimicrobial resistance of hypervirulent Klebsiella pneumoniae: epidemiology, hypervirulence-associated determinants, and resistance mechanisms.
Front Cell Infect Microbiol, 7 (2017), pp. 483
[15]
W. Li, G. Sun, Y. Yu, N. Li, M. Chen, R. Jin, Y. Jiao, H. Wu.
Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China.
Clin Infect Dis, 58 (2014), pp. 225-232
[16]
J. Lin, F. Chang, C. Fung, J. Xu, H. Cheng, J. Wang, L. Huang, L. Siu.
High prevalence of phagocytic-resistant capsular serotypes of Klebsiella pneumoniae in liver abscess.
Microbes Infect, 6 (2004), pp. 1191-1198
[17]
Y.C. Liu.
Klebsiella pneumoniae liver abscess associated with septic endophthalmitis.
Arch Intern Med, 146 (1986), pp. 1913-1916
[18]
Y. Liu, J.Y. Wang, W. Jiang.
An increasing prominent disease of Klebsiella pneumoniae liver abscess: etiology, diagnosis, and treatment.
Gastroenterol Res Pract, 2013 (2013), pp. 258514
[19]
L. Meddings, R.P. Myers, J. Hubbard, A.A. Shaheen, K.B. Laupland, E. Dixon, C. Coffin, G.G. Kaplan.
A population-based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends.
Am J Gastroenterol, 105 (2010), pp. 117-124
[20]
R. Nakamura-Silva, M. Oliveira-Silva, J.P.R. Furlan, E.G. Stehling, C.E.S. Miranda, A. Pitondo-Silva.
Characterization of multidrug-resistant and virulent Klebsiella pneumoniae strains belonging to the high-risk clonal group 258 (CG258) isolated from inpatients in northeastern Brazil.
Arch Microbiol, 203 (2021), pp. 4351-4359
[21]
A.M. Parrott, J. Shi, J. Aaron, D.A. Green, S. Whittier, F. Wu.
Detection of multiple hypervirulent Klebsiella pneumoniae strains in a New York City hospital through screening of virulence genes.
Clin Microbiol Infect, 27 (2021), pp. 583-589
[22]
B. Rossi, M.L. Gasperini, V. Leflon-Guibout, A. Gioanni, V. de Lastours, G. Rossi, S. Dokmak, M. Ronot, O. Roux, M.-H. Nicolas-Chanoine, B. Fantin, A. Lefort.
Hypervirulent Klebsiella pneumoniae in cryptogenic liver abscesses, Paris, France.
Emerg Infect Dis, 24 (2018), pp. 221-229
[23]
T.A. Russo, U. MacDonald, S. Hassan, E. Camanzo, F. LeBreton, B. Corey, P. McGann.
An assessment of siderophore production, mucoviscosity, and mouse infection models for defining the virulence spectrum of hypervirulent Klebsiella pneumoniae.
[24]
T.A. Russo, C.M. Marr.
Hypervirulent Klebsiella pneumoniae.
Clin Microbiol Rev, 32 (2019),
[25]
T.A. Russo, R. Olson, C.-T. Fang, N. Stoesser, M. Miller, U. MacDonald, A. Hutson, J.H. Barker, R.M. La Hoz, J.R. Johnson.
Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae.
J Clin Microbiol, 56 (2018),
[26]
D. Serban, A. Popa Cherecheanu, A.M. Dascalu, B. Socea, G. Vancea, D. Stana, G.C. Smarandache, A.D. Sabau, D.O. Costea.
Hypervirulent Klebsiella pneumoniae endogenous endophthalmitis – a global emerging disease.
Life (Basel), 11 (2021), pp. 676
[27]
A.S. Shon, R.P.S. Bajwa, T.A. Russo.
Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed.
Virulence, 4 (2013), pp. 107-118
[28]
C. Sifri, L. Maddof.
Infections of the liver and biliary system (liver abscess, cholangitis, cholecystitis).
Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 9th ed., pp. 1037
[29]
L.K. Siu, K.-M. Yeh, J.-C. Lin, C.-P. Fung, F.-Y. Chang.
Klebsiella pneumoniae liver abscess: a new invasive syndrome.
Lancet Infect Dis, 12 (2012), pp. 881-887
[30]
M. Sohrabi, M. Alizade Naini, A. Rasekhi, M. Oloomi, F. Moradhaseli, A. Ayoub, A. Bazargani, Z. Hashemizadeh, F. Shahcheraghi, F. Badmasti.
Emergence of K1 ST23 and K2 ST65 hypervirulent Klebsiella pneumoniae as true pathogens with specific virulence genes in cryptogenic pyogenic liver abscesses Shiraz Iran.
Front Cell Infect Microbiol, 12 (2022), pp. 964290
[31]
A. Vila.
Appearance of Klebsiella pneumoniae liver abscess syndrome in Argentina: case report and review of molecular mechanisms of pathogenesis.
Open Microbiol J, 5 (2011), pp. 107-113
[32]
X. Wang, Y. Xie, G. Li, J. Liu, X. Li, L. Tian, J. Sun, H.-Y. Ou, H. Qu.
Whole-genome-sequencing characterization of bloodstream infection-causing hypervirulent Klebsiella pneumoniae of capsular serotype K2 and ST374.
Virulence, 9 (2018), pp. 510-521
[33]
K.L. Wyres, M.M.C. Lam, K.E. Holt.
Population genomics of Klebsiella pneumoniae.
Nat Rev Microbiol, 18 (2020), pp. 344-359
[34]
M. Ye, J. Tu, J. Jiang, Y. Bi, W. You, Y. Zhang, J. Ren, T. Zhu, Z. Cao, Z. Yu, C. Shao, Z. Shen, B. Ding, J. Yuan, X. Zhao, Q. Guo, X. Xu, J. Huang, M. Wang.
Clinical and genomic analysis of liver abscess-causing Klebsiella pneumoniae identifies new liver abscess-associated virulence genes.
Front Cell Infect Microbiol, 6 (2016), pp. 165
[35]
K.M. Yeh, J.C. Lin, F.Y. Yin, C.P. Fung, H.C. Hung, L.K. Siu, F.Y. Chang.
Revisiting the importance of virulence determinant magA and its surrounding genes in Klebsiella pneumoniae causing pyogenic liver abscesses: exact role in serotype K1 capsule formation.
J Infect Dis, 201 (2010), pp. 1259-1267
[36]
W.-L. Yu, W.-C. Ko, K.-C. Cheng, H.-C. Lee, D.-S. Ke, C.-C. Lee, C.-P. Fung, Y.-C. Chuang.
Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan.
Clin Infect Dis, 42 (2006), pp. 1351-1358
[37]
F. Yu, J. Lv, S. Niu, H. Du, Y.-W. Tang, J.D.D. Pitout, R.A. Bonomo, B.N. Kreiswirth, L. Chen.
Multiplex PCR analysis for rapid detection of Klebsiella pneumoniae carbapenem-resistant (sequence type 258 [ST258] and ST11) and hypervirulent (ST23, ST65, ST86, and ST375) strains.
J Clin Microbiol, 56 (2018),
Copyright © 2024. The Author(s)
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.ram.2024.10.008
No mostrar más